Osteobiologic utilization is one of the most variable and costly areas in surgical care. Rapid product proliferation, limited comparative evidence and vendor-driven influence have led to inconsistent practices and escalating spend. This session will explore a structured approach to reducing clinical variation and costs through an evidence-based osteobiologic formulary and vendor consolidation strategy. Attendees will learn how to align surgeon choice with quality and safety standards, eliminate bill-only practices and leverage vendor partnerships for significant financial impact.
